md13237.doc - Mediacom


Dec 3, 2012 (5 years and 7 months ago)


UBM Sees Significant Rise in Interest in 2009 for Indian
Pharma Shows

MAARSEN, Jan. 20 /PRNewswire

20% increases in exhibitors, coupled with 5% rise in attendees,

reflects continued growth in region's Pharmaceutical industry

Reflecting the continued growth in the fine chemicals, pharmaceuticals and

pharmaceuticals industries on the Indian sub
continent, leading events

organisers UBM International Media and its sister company UBM India Pvt. Ltd.

today announced that

they had recorded significant gains in both exhibitor and

attendee numbers at CPhI India, P
MEC India and related pharma services events,

held in Mumbai from December 1st to 3rd 2009. The combined exhibitions have

accelerated since their inception in 20
06, gaining wide recognition as the

largest and most important pharma services business gatherings in India and

South Asia.

Moving strongly ahead of pre
event expectations, the four events, held at

the Bombay Exhibition Centre and comprising of the
third CPhI India, second

MEC India and debut editions of BioPh India and ICSE India, hosted over 770

exhibitors from 20 countries, up over 20% on the 600 exhibitors in 2007 and

welcomed 26,300 attendees, an increase of almost 5% on 2007's 25,831

s. Close
capacity attendance was also achieved at the two

associated conferences

Biosimilars India and the Indian Pharma Summit.

"Our 2009 India events were ahead of expectations in all key respects,"

said CPhI Event Director Annemieke Timmers. "
Most importantly, we had

excellent feedback on the importance of the exhibitions for business


and saw important foundations laid for even stronger events

later this year."

Market growth and momentum were a fitting backdrop to the launch o
f the

BioPh India event

focused on the convergence of technologies and business

models in pharma and healthcare biotechnology

and the debut of ICSE India,

with emphasis on the very fast
growing outsourcing and contract services


With UBM, t
he Government of India's new Department of Pharmaceuticals

staged the first India Pharma Summit, which attracted over 800 delegates to

its broad
ranging agenda across the issues, opportunities and challenges for

India as an emerging global pharma hub.

Staged in the BioPh pavilion, the Biosimilars India 2009 conference was

also fully attended for its 17 sessions over three half
day modules.

"With the BioPh India and ICSE India launches and a strong conference

programme, Mumbai 2009 was our stronges
t Indian event since the family was

launched here in 2006," noted ICSE, BioPh and P
MEC Event Director Haf


Key industry organisations that supported the 2009 exhibitions included


the Government of India's pharmaceutical export pr

council; the Indian Drug Manufacturers Association (IDMA); the Organisation

of Pharmaceutical Producers of India (OPPI) and the Bulk Drug Manufacturers

Association (India) (BDMA).

For 2010, CPhI India, with ICSE, P
MEC and BioPh India will ret
urn to the

Bombay Exhibition Centre on the same dates as 2009: 1

3 December.

UBM International Media's annual sister events for the pharma ingredients

and services sector include Worldwide (Europe

October); Japan (April);

China (June); and South A
merica (August). For websites, see:; www.cphi
-; www.pmec
-; and www.bioph
- .

Notes for Editors:


UBM International Media operates market
leading global exhibition

brands an
d their complementary media products.


The CPhI pharmaceutical ingredients and related sector exhibitions

currently number over 15 highly
regarded annual events. The portfolio

also includes Informex (specialty chemicals), Food Ingredients

(health & beauty industry) and Sea Trade (cruise industry).


Worldwide locations for its events include China, India, Japan, North

America, Brazil, Africa and Europe. More than 330,000 business

professionals and marketers vis
it UBM exhibitions each year. The

exhibitions portfolio is managed from Holland. UBM International Media

has approximately 1,200 employees in the UK, US, Asia and Europe. See

SOURCE: UBM International Media

T: Rob Sahi (CPhI),

UBM International Media,

+ 31 (0)346

or Ian O'Malley (ICSE, P
MEC, BioPh),

UBM International Media,

+ 31 (0)346

or Richard Kerns,

Impress PR,

+44 (0) 161